Rubius Therapeutics Inc (Over The Counter Market:RUBY)

0.019
Delayed Data
As of 12:00am ET
 +0.0007 / +3.83%
Today’s Change
0.00
Today|||52-Week Range
0.42
-89.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

--
Revenue and IncomeNet Revenues0.000.000.00----
Depreciation And Amortization118.0K447.0K1.3M--
 
 
 
 
 
Operating ExpensesGross Income-118.0K-447.0K-1.3M--
 
 
 
 
General Expenses10.7M42.8M90.4M--
 
 
 
 
Research And Development8.4M21.2M51.8M--
 
 
 
 
Total Operating Expenses10.9M43.3M91.7M--
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.9M-43.3M-91.7M--
 
 
 
 
Extraordinary Credit1.0K0.000.00--
 
 
Extraordinary Charge---785.0K-2.2M--
 
 
 
Interest Expense On Debt149.0K309.0K464.0K--
 
 
 
 
Other Expenses-16.0K511.0K5.1M--
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.0M-43.8M-89.2M--
 
 
 
 
Preferred Dividend-748.0K-656.0K0.00--
 
 
 
Net Income-11.0M-43.8M-89.2M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS78.9M78.9M39.3M--
 
 
 
 
Shares To Calculate EPS Diluted78.9M78.9M39.3M--
 
 
 
 
 
Earnings Per ShareEPS-$0.15-$0.56-$2.27--
 
 
 
 
EPS Diluted-$0.15-$0.56-$2.27--